Trial intelligence / Profile preview

EVARREST Fibrin Sealant Patch for Mild or Moderate Bleeding in Pediatric Surgery

2013-003557-24Phase 3Unknown

Sponsor
Ethicon
Start
Dec 2013
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised trial of Fibrin Pad in Not applicable (2 arms), sponsored by Ethicon. Primary endpoint: Absolute time to haemostasis. Status: unknown.

02

Drugs

Fibrin Pad
03

Conditions

Not applicable

Beyond the preview

Go deeper on 2013-003557-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003557-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call